UCLA Researchers Develop Low-Cost Blood Test to Detect Multiple Cancers And Other Diseases From a Single Sample
oncodaily - The new method analyzes genome-wide methylation of DNA circulating in the bloodstream to detect liver, lung, ovarian and stomach cancers, as well as several non-cancer conditions. UCLA scientists have developed […]
AI Summary: Researchers at UCLA introduced a low-cost blood test capable of detecting multiple cancers and other diseases from a single sample, promising broader screening reach and earlier detection. If validated at scale, the technology could lower barriers to multi-cancer screening, reshape diagnostic pathways, and offer cheaper, simpler surveillance—assuming the usual caveats about follow-up testing and false positives.
- Frontline: ctDNA and cfDNA - monitoring, screening, and reliability questions (4)
- On location: early-detection debates, AI risk stratification and screening value (4)
- On the ground: UCLA’s inexpensive blood test expands multi-disease detection (4)
- All Other Stories
Frontline: ctDNA and cfDNA - monitoring, screening, and reliability questions
On location: early-detection debates, AI risk stratification and screening value
On the ground: UCLA’s inexpensive blood test expands multi-disease detection
All Other Stories
Too young for the MMR shot, babies become 'sitting ducks' in measles outbreaks
medicalxpress - With baby Arthur too young for the measles vaccine and a sibling due in June, the Otwells grew nervous when the threat of the highly contagious virus started factoring into their grocery run.
AI Summary: Health reporting highlights that infants below the eligible age for the MMR vaccine remain highly vulnerable during measles outbreaks, effectively "sitting ducks" until immunization is possible. Public-health experts warn that gaps in community immunity and outbreak control measures disproportionately endanger these youngest children, underscoring the need for stronger herd-protection and targeted outbreak responses.
CMS proposes mandatory hospital-bundled model for joint replacements
Ella Jeffries / beckershospitalreview - CMS is proposing a mandatory, nationwide episode-based payment model for joint replacements that would hold most hospitals responsible for Medicare spending tied to a patient’s surgery and recovery. Beginning Oct. 1, 2027, the model — referred to as CJR-X…
AI Summary: CMS unveiled a plan to make hospitals participate in a mandatory bundled-payment model for joint replacement surgeries, offering a 2.4% payment increase tied to the new program. The proposal would standardize payment and care pathways nationwide, shifting financial and operational risk onto hospitals while aiming to curb costs and improve outcomes.
AbbVie sues HHS over 340B patient definition
Ella Jeffries / beckershospitalreview - AbbVie has filed a lawsuit challenging federal guidance on how “patient” is defined under the 340B program, according to an April 8 press release. The company said the current definition, based on guidance issued in 1996, allows covered entities to claim …
AI Summary: AbbVie has filed suit challenging HHS’s interpretation of the 340B program, arguing the agency’s “patient” definition and related guidance are outdated and legally flawed. The company seeks judicial clarity that could reshape who qualifies for discounted drugs and how hospitals and manufacturers navigate the program — yes, the pricing drama continues.
An international mega-analysis of psychedelic drug effects on brain circuit function
Manesh Girn / nature - Nature Medicine, Published online: 06 April 2026; doi:10.1038/s41591-026-04287-9Analysis of neuroimaging datasets across five major psychedelics revealed a shared brain signature and provides a comprehensive insight into how these drugs reorganize brain a…
AI Summary: An international neuroimaging mega‑analysis traced psychedelic drugs’ effects on cortical networks, revealing consistent changes in brain connectivity that correlate with altered perception and cognition. The pooled study provides a stronger, replicated picture of how these compounds act on neural circuits, informing both therapeutic prospects and safety discussions.
RFK Jr. launching health podcast to expose ‘hypocrisy’ and ‘corruption’
fiercehealthcare - Robert F. Kennedy Jr. is starting a podcast. Unveiling the show on social media, the Department of Health and Human Services (HHS) secretary framed the podcast as a response to public health problems that he said have made “many of us ... come to the conc…
AI Summary: Robert F. Kennedy Jr. is debuting a health-focused podcast promising to call out what he characterizes as hypocrisy and corruption in medicine and public health. The show aims to amplify skeptical takes on mainstream health institutions and policies, positioning itself as a combative platform for contrarian voices and investigations.
HHS updates vaccine panel requirements after judge's decision
medicalxpress - Health officials are changing the rules for who can serve on a key vaccine advisory panel after a judge ruled that many current members are unqualified.
AI Summary: Following a court decision, HHS has revised vaccine advisory committee requirements and the CDC is moving forward with changes to its vaccine advisory structure. Federal agencies are retooling membership and operating rules to restore advisory functions while navigating legal limits, aiming to keep vaccine guidance intact — whether the courtroom likes it or not.
- CDC delays vaccine-effectiveness reports; vaccine-priority lessons examined (4)
- Courts and states press legal challenge to HHS restructuring (4)
- HHS reconstitutes vaccine advisory panel under new charter and appointments (2)
- Kennedy-driven shake-up amplifies vaccine-safety focus and skepticism voices (2)
- All Other Stories
CDC delays vaccine-effectiveness reports; vaccine-priority lessons examined
Courts and states press legal challenge to HHS restructuring
HHS reconstitutes vaccine advisory panel under new charter and appointments
Kennedy-driven shake-up amplifies vaccine-safety focus and skepticism voices
All Other Stories
Disruption expected as six-day doctors' strike begins
bbc - The NHS is advising patients in England to only use emergency services when necessary but attend any confirmed appointments.
AI Summary: A coordinated six‑day doctors' strike has caused significant disruption across hospitals and clinics, leading to postponed appointments, diverted emergency visits and heightened anxiety among patients awaiting care. Health leaders urge targeted communication and contingency staffing while negotiators and striking doctors trade barbs — and patients try not to become collateral damage.
- Cancellations provoke fury as doctors warn of staffing crisis (3)
- Healthcare labour unrest: unions, petitions and declining staff morale (3)
- NHS urges patients: attend confirmed appointments, avoid A&E (3)
- Other: research inclusion debate and volatile crypto markets (3)
- All Other Stories
Cancellations provoke fury as doctors warn of staffing crisis
Healthcare labour unrest: unions, petitions and declining staff morale
NHS urges patients: attend confirmed appointments, avoid A&E
Other: research inclusion debate and volatile crypto markets
All Other Stories
Can a single therapy session make a difference? Yes, with the right mindset
abcnews - Can a single therapy session make a difference
AI Summary: Experts report that a single, well‑structured therapy session can produce meaningful short‑term benefits for some patients when expectations, mindset, and therapeutic focus align. It’s not a miracle cure, but the finding nudges clinicians and policymakers toward pragmatic, low‑burden interventions that can provide rapid relief while longer‑term care is arranged.
Rabi Hanna: First-in-Human CRISPR/Cas12a Therapy in Sickle Cell Disease
oncodaily - Rabi Hanna, Pediatric Blood and Marrow Transplant Program Director, and Chairman at the Department of Pediatric Hematology-Oncology and BMT at Cleveland Clinic, shared a post on LinkedIn: “I am excited […]
AI Summary: A first‑in‑human CRISPR/Cas12a therapy for sickle cell disease has treated initial patients, building on preclinical gene‑editing successes that reversed severe disease in models. The advance underscores rapid translation from lab to clinic and renews hope for durable cures—while reminding everyone that the safety and long‑term durability questions remain firmly on the table.
Uveal Melanoma: ESMO–EURACAN Clinical Practice Guideline
esmo - This ESMO–EURACAN CPG provides key recommendations for the diagnosis, staging, treatment and follow-up for uveal melanoma. It includes percutaneous hepatic perfusion and tebentafusp as treatment options for metastatic disease, reflecting emerging evidence…
AI Summary: ESMO–EURACAN released a comprehensive clinical practice guideline for uveal melanoma covering diagnosis, staging, surveillance and systemic management. The guidance clarifies best practices for multidisciplinary care, risk stratification and therapeutic sequencing, aiming to standardize treatment and follow‑up for a rare but high‑risk ocular tumour.
Bowelbabe Fund celebrates raising £20m by announcing the Bowelbabe Vaccine
Sophie Wedekind / cancerresearchuk - The Bowelbabe Fund has raised more that £20 million and has announced the next wave of funded projects, including the Bowelbabe Vaccine.The post Bowelbabe Fund celebrates raising £20m by announcing the Bowelbabe Vaccine appeared first on Cancer Research U…
AI Summary: The Bowelbabe Fund celebrated a £20 million fundraising milestone and unveiled plans for a Bowelbabe Vaccine initiative, drawing high‑profile support. Organizers framed the cash infusion as a catalyst for prevention and research efforts, while public endorsements highlighted momentum — and the fundraising thermometer that finally stopped making them blush.
FDA identifies eight deaths tied to Amgen's Tavneos
Max Bayer / endpoints - The FDA on Tuesday flagged more than 70 cases of severe liver injury and eight deaths associated with Amgen’s autoimmune treatment Tavneos, but the company said it previously notified the agency about the risk of ...
AI Summary: The FDA has tied eight patient deaths to Amgen’s drug Tavneos, prompting heightened regulatory review and industry concern. Reports outline safety signals and agency actions as clinicians and manufacturers reassess risk‑benefit profiles, while regulators weigh labeling, monitoring or other interventions to protect patients.
Congo says its mpox outbreak is over after 2 years and more than 2,200 suspected deaths
abcnews - Congo has declared the end of a two-year mpox outbreak, which is believed to have caused over 2,200 deaths
AI Summary: Republic of the Congo announced its prolonged mpox outbreak has ended after roughly two years and more than 2,200 suspected deaths, even as genomic surveillance uncovered co-circulating clades, including evidence of clade IIb lineage A.2.2. Health officials now face the twin tasks of documenting lessons and monitoring for lingering transmission.
White House floats 12.5% budget cut for HHS in FY2027, reiterates reorganization plan
fiercehealthcare - The requested budget cut is about half of what the administration asked, and was denied, last year. However, plans for reorganizing agencies under an Administration for a Healthy America persist, as do calls to eliminate various programs and centers the W…
AI Summary: The administration has floated a plan to cut HHS funding by roughly 12–12.5% in FY2027 while pursuing agency reorganization. The proposal targets discretionary programs including research funding, prompting scientific groups to urge Congress to reject the NIH reductions and warn of downstream impacts on biomedical research and patient care.
- Researchers, cancer groups warn NIH cuts will harm patients (6)
- White House pushes deep HHS cuts, agency reorganization (4)
- All Other Stories
Researchers, cancer groups warn NIH cuts will harm patients
White House pushes deep HHS cuts, agency reorganization
All Other Stories
Why 131 Hospitals Are Suing HHS Over Alleged Underpayment
Katie Adams / medcitynews - A group of 131 hospitals has sued HHS over a CMS policy they say improperly reduces Medicare disproportionate share hospital (DSH) payments. The lawsuit is the latest in a decade-long legal battle over how the agency counts patient days and calculates pay…
AI Summary: One hundred thirty‑one hospitals have filed suit challenging HHS’s 2023 Disproportionate Share Hospital calculation, arguing the agency’s formula undercounts uncompensated care and systematically underpays safety‑net providers. The plaintiffs seek to overturn the rule and recover alleged shortfalls, warning that ongoing underpayment threatens hospital finances and patient access.
CMS finalizes Medicare Advantage star ratings overhaul, sending billions of dollars more to insurers
Rebecca Pifer Parduhn / healthcaredive - Regulators cut almost a dozen metrics that factor into the quality ratings and reverted back to an older and more generous bonus system. MA plans will get more than $18 billion in additional payments over the next decade as a result.
AI Summary: The Centers for Medicare & Medicaid Services locked in a sweeping overhaul of Medicare Advantage star ratings that will shift billions of dollars in payments and alter plan incentives. The ruling adjusts rating calculations and enrollment provisions, prompting industry and provider concerns about downstream effects on access, plan behavior, and provider-network stability.
E.P.A. Targets Microplastics and Drugs in Drinking Water
Hiroko Tabuchi and Maxine Joselow / nytimes - The move drew praise from leaders of the Make America Healthy Again movement who had recently criticized the agency’s handling of toxic chemicals.
AI Summary: Federal agencies are moving from polite warnings to action on contaminants people actually drink. The EPA is targeting microplastics and trace pharmaceuticals in drinking water, while ARPA‑H is pouring funding into health-impact studies, and other agencies are considering formal contaminant designations to force testing, cleanup and new standards. Small particles, big headache.
Group sues CMS for details on Medicare AI prior authorization pilot
Andrew Cass / beckershospitalreview - Digital rights advocacy organization the Electronic Frontier Foundation has filed a Freedom of Information Act lawsuit against CMS seeking information on how the AI algorithms work in its traditional Medicare prior authorization pilot. CMS’ Wasteful and I…
AI Summary: A coalition of tech and privacy groups has sued CMS seeking detailed records about a Medicare pilot that uses AI to automate prior authorization decisions. Plaintiffs argue the agency failed to provide transparency on algorithms, data inputs and patient safeguards, demanding documents to assess legal, safety and fairness risks before the program expands.
CMS: This year's open enrollment brought fewer signups, higher premiums
fiercehealthcare - The administration's official numbers on the 2026 Open Enrollment Period outlined drops in new customers and automatic re-enrollment, the latter of which CMS said stemmed from its crackdown on improper enrollments. Average monthly premiums also increased …
AI Summary: CMS data show this year's ACA open enrollment produced fewer new signups while benchmark premiums climbed, nudging many consumers into higher‑deductible plans. Enrollment sits near 23.1 million for 2026, but the mix of coverage is tilting toward cost‑sharing over comprehensiveness, raising concerns about affordability and surprising out‑of‑pocket shocks for vulnerable families.